Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PETROS GRIVAS

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1740443852
CMS profile
34215
Location
SEATTLE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$122,958.24

60 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
EMD Serono, Inc. $41,897.60 30
Merck KGaA $20,250.00 3
Merck Sharp & Dohme Corporation $7,500.00 4
F. Hoffmann-La Roche AG $7,425.00 3
PFIZER INC. $7,362.00 3
Seagen Inc. $7,130.00 3
Regeneron Pharmaceuticals, Inc. $6,877.50 2
UROGEN PHARMA, INC. $6,400.00 1
AstraZeneca Pharmaceuticals LP $5,480.00 2
Gilead Sciences, Inc. $4,440.64 3
E.R. Squibb & Sons, L.L.C. $4,132.50 3
Astellas Pharma Global Development $1,860.00 1
Incyte Corporation $1,125.00 1
Exelixis Inc. $1,078.00 1

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

60 matching records · $122,958.24 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 60 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 60.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $2,740.0011/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829793807 CMS
EMD Serono, Inc. $1,500.0011/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849181695 CMS
E.R. Squibb & Sons, L.L.C. $1,482.5011/16/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783516943 CMS
UROGEN PHARMA, INC. $6,400.0011/11/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026826678563 CMS
Gilead Sciences, Inc. $3,600.0010/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845882165 CMS
E.R. Squibb & Sons, L.L.C. $1,500.0010/21/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783516925 CMS
Gilead Sciences, Inc. $90.6410/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848202805 CMS
Seagen Inc. $2,480.0010/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832179695 CMS
EMD Serono, Inc. $191.3210/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151243 CMS
EMD Serono, Inc. $239.1610/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151259 CMS
EMD Serono, Inc. $143.4910/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151263 CMS
EMD Serono, Inc. $179.3710/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151283 CMS
EMD Serono, Inc. $913.1310/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151295 CMS
EMD Serono, Inc. $1,141.4210/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151309 CMS
EMD Serono, Inc. $684.8510/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151313 CMS
EMD Serono, Inc. $856.0610/07/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151333 CMS
EMD Serono, Inc. $7,500.0009/20/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849216453 CMS
EMD Serono, Inc. $271.8709/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151369 CMS
EMD Serono, Inc. $565.8509/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151377 CMS
EMD Serono, Inc. $254.8809/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151395 CMS
EMD Serono, Inc. $553.2909/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151411 CMS
EMD Serono, Inc. $271.8709/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151423 CMS
EMD Serono, Inc. $495.0009/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151437 CMS
EMD Serono, Inc. $246.2109/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151441 CMS
EMD Serono, Inc. $234.2809/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151459 CMS
EMD Serono, Inc. $242.6809/10/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151471 CMS
Merck Sharp & Dohme Corporation $3,500.0009/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848416767 CMS
Astellas Pharma Global Development $1,860.0008/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801077239 CMS
Regeneron Pharmaceuticals, Inc. $3,275.0008/13/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809681105 CMS
Merck KGaA $6,000.0008/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026840490401 CMS
F. Hoffmann-La Roche AG $990.0008/01/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835962425 CMS
Exelixis Inc. $1,078.0007/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026838871779 CMS
Incyte Corporation $1,125.0007/23/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835543835 CMS
Regeneron Pharmaceuticals, Inc. $3,602.5007/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809681103 CMS
PFIZER INC. $1,875.0007/02/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833393467 CMS
PFIZER INC. $3,687.0006/17/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833393465 CMS
Merck Sharp & Dohme Corporation $1,500.0006/02/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848417827 CMS
Merck KGaA $6,750.0005/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026840490403 CMS
AstraZeneca Pharmaceuticals LP $2,740.0005/26/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829916665 CMS
EMD Serono, Inc. $339.8305/11/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151365 CMS
F. Hoffmann-La Roche AG $2,640.0005/03/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835962423 CMS
PFIZER INC. $1,800.0004/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832498343 CMS
Gilead Sciences, Inc. $750.0004/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845882163 CMS
Merck Sharp & Dohme Corporation $2,000.0004/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848492077 CMS
EMD Serono, Inc. $309.8504/21/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151337 CMS
EMD Serono, Inc. $217.9004/21/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151345 CMS
Seagen Inc. $2,170.0003/31/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832179511 CMS
EMD Serono, Inc. $4,966.4803/30/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151183 CMS
EMD Serono, Inc. $16,500.0003/24/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849216413 CMS
EMD Serono, Inc. $271.8703/22/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849151479 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $84,273.32 89
PY2020 $78,217.39 32
PY2021 $122,958.24 60
PY2022 $98,602.50 58
PY2023 $52,324.57 40
PY2024 $91,571.70 62
PY2025 $100,379.95 44

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
PETROS GRIVAS, NPI 1740443852. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1740443852.
APA 7
IndustryPayments. (2026). PETROS GRIVAS, NPI 1740443852 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1740443852
Bluebook
PETROS GRIVAS, NPI 1740443852, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1740443852.

Source: Centers for Medicare & Medicaid Services, Open Payments.